Repligen (RGEN) Net Income towards Common Stockholders (2010 - 2026)

Repligen (RGEN) has reported Net Income towards Common Stockholders for 17 consecutive years, with $5.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Net Income towards Common Stockholders fell 66.31% year-over-year to $5.0 million; the TTM figure through Jun 2026 stood at $61.8 million (up 166.64% YoY), while the FY2025 annual figure was $69.0 million, up 166.15% from the prior year.
• Net Income towards Common Stockholders declined to $5.0 million in Q2 2026 per RGEN's latest filing, from $8.4 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $49.9 million in Q2 2022 and bottomed at -$112.7 million in Q4 2024.
• Historically, Net Income towards Common Stockholders has averaged $13.2 million across 5 years, with a median of $14.9 million in 2025.
• Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders sank 1435.78% — and 2025, when it surged 2379.97%.
• Repligen's Net Income towards Common Stockholders stood at $48.7 million in 2022, then plunged by 82.68% to $8.4 million in 2023, then tumbled by 1435.78% to -$112.7 million in 2024, then surged by 129.69% to $33.5 million in 2025, then plunged by 85.03% to $5.0 million in 2026.
• Business Quant data shows RGEN's Net Income towards Common Stockholders at $5.0 million in Q2 2026, $8.4 million in Q1 2026, and $33.5 million in Q4 2025.